endometrial cancer
Conditions
Interventions
Gold Standard:Pathological examination
Index test:fluorescent 
labeling 
technology 
of 
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 and 70 years old woman; 2. Diagnostic curettage of endometrium suggests endometrioid adenocarcinoma; 3. Pelvic magnetic resonance imaging showed that the lesion was confined to the uterus; 4. There were no suspicious nodules in pelvic and abdominal magnetic resonance imaging (according to RECIST 1.1); 5. ECOG performance status 0-1 points; 6. Blood routine and biochemical examination: white blood cells (> 4000 cells/mm3), platelets (> 10,000/mm3), hemoglobin (> 8.0 gm/dL), serum creatinine (< 1.3 mg/dL), serum urea nitrogen (< 1.5 mg/dL); 7. Ability to sign informed consent and follow up.
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactation; 2. Double malignant tumors; 3. Received neoadjuvant chemotherapy and/or radiotherapy; 4. allergic reaction to blue dyes, isotopes or ICG; 5. Severe cardiopulmonary vascular diseases lead to intolerance of surgery. 6. Psychiatric patients; 7. Intraoperative sentinel lymph node status was not in accordance with the enrollment (i.e. one side was negative, one side was not visualized; lymph node invasion; no sentinel lymph node, other considerations were not suitable for enrollment).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| disease-free survival;quality of life;overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time;intraoperative bleeding;pelvic lymphocyst;infection;length of stay in the hospital;hospitalization costs; | — |
Countries
China
Contacts
Public ContactZhu Tao
Zhejiang Cancer Hospital
Outcome results
None listed